Background and Aim: Zingiber officinale (ZO) is commonly used as one of natural food additives. This study was designed to evaluate immunomodulatory and antioxidant effect of Zingiber officinale extract (ZO) against lead toxicity in rats.
Material and Methods:Forty eight male albino rats were divided into 6 equal groups and treated daily for 21 days. Group I; normal control, Group II treated with lead acetate in drinking water at a dose of 1000 ppm. Groups III and IV received 1000 ppm of lead and administrated orally ZO ethanol extract at 200 and 400 mg/kg bw doses, respectively. Groups V and VI, were administrated orally ZO extract at doses 200 and 400 mg /kg bw daily, respectively. At the end of the treatment period, blood samples were collected from all groups to assess some selective humoral immunological and biochemical parameters.
Results:In the lead exposed group, Tumor necrosis factor-α (TNF α), Interleukin-1β (IL-1 β), Interleukin 6 (IL-6), Interleukin 10 (IL-10) and malnodiladhyide (MDA) were significantly increased compared with the control group, while gamma interferon (IFN-γ), glutathione (GSH), superoxide dismutase (SOD), total antioxidant (TAC),were decreased. Regarding, liver and renal markers, in lead treatment group, there were significantly increased in the activities of amino transferases (ALT, AST) urea; creatinine and phosphorous, while total plasma proteins, albumin and calcium were significantly decreased. The ZO extract alone at the two tested doses did not induce any significant changes in hepatorenal markers, while the antioxidant markers were significant increase. ZO extract in combination with cadmium significantly reduced the elevation of serum IL-1, IL-6, TNF, IL-10 and MDA, in addition to augmenting the antioxidant enzyme activities. Moreover, ZO ameliorate lead induced hepatorenal damage.
Conclusion:It could be concluded that the ZO extract has a potential immunomodulatory, antioxidant activity and a protective effect against lead toxicity.